Friday 6 November 2026
Export ZCMD’s income statement to Excel — free account
Zhongchao Inc.
ZCMD Healthcare Health Information Services
Zhongchao Inc.’s revenue for fiscal 2025 (year ended December 2025) was $11.4 million, down 28.3% from fiscal 2024.
0.97
0.01
+1.04%
Follow ZCMD
Alert me
| Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 | Dec '20 | Dec '19 | Dec '18 | Dec '17 | |
|---|---|---|---|---|---|---|---|---|---|
Piotroski F-Score |
3 | 5 | 5 | 3 | 4 | 3 | — | — | — |
P/E ratio |
0.00 | 0.00 | 0.00 | 0.00 | 139,395.16 | 74,396.29 | 25.00 | 25.00 | 25.00 |
Altman Z-Score |
4.34 | 3.85 | 1.04 | 3.96 | 8.78 | 10.30 | — | — | — |
P/S ratio |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
P/FCF ratio |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Altman Z″-Score (non-manufacturers) |
15.87 | 17.89 | 6.22 | 9.18 | 14.11 | 17.78 | 13.19 | 10.75 | — |
P/Operating CF |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Beneish M-Score |
(4.20) | (1.11) | (5.32) | (2.43) | (2.72) | (0.74) | (0.43) | — | — |
P/B ratio |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Price to Tangible BV |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
EV/Sales |
(0.41) | (0.38) | (0.39) | (0.37) | (0.39) | (0.50) | 0.00 | 0.00 | 0.00 |
EV/EBITDA |
1.88 | 1.76 | 1.81 | 6.06 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
EV/Operating CF |
(6.59) | 5.02 | 3.90 | (3.75) | (12.66) | 4.97 | 0.00 | 0.00 | 0.00 |
EV/FCF |
3.22 | 1.47 | 2.76 | 9.54 | 4.63 | 2.94 | 0.00 | 0.00 | 0.00 |
Quick Ratio |
10.94 | 11.61 | 5.97 | 4.57 | 6.64 | 9.20 | 5.48 | 4.75 | 3.90 |
Current Ratio |
11.11 | 12.22 | 6.99 | 5.45 | 7.59 | 9.92 | 6.15 | 5.38 | 4.10 |
Net Debt/EBITDA |
2.36 | 118.73 | 1.05 | 4.68 | (679.96) | (3.65) | (2.09) | (2.52) | (4.51) |
Debt/Assets |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 5.18% | 0.00% |
Debt/Equity |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.06 | 0.00 |
Asset Turnover |
0.45 | 0.63 | 0.62 | 0.38 | 0.46 | 0.68 | 0.94 | 1.83 | 0.93 |
Operating CF/Net income |
(0.13) | 2.29 | 0.00 | 0.23 | 11.99 | (0.23) | 0.35 | 0.43 | (0.35) |
Capex/Depreciation |
(0.53) | (13.18) | (1.56) | (1.31) | (5.27) | (0.79) | (12.76) | (28.08) | 0.00 |
Interest Coverage |
— | — | — | — | — | — | — | — | 121.23 |
| (27.00%) | (2.85%) | (41.94%) | (8.97%) | 0.74% | 18.90% | 30.29% | 36.39% | 18.40% | |
| (25.22%) | (2.56%) | (35.97%) | (7.85%) | 0.67% | 16.97% | 25.46% | 42.99% | 14.55% | |
ROIC |
(44.60%) | (1.93%) | (109.36%) | (8.80%) | (1.09%) | 19.05% | 30.33% | 67.54% | 0.00% |
Return on Tangible Assets |
(29.61%) | (2.79%) | (58.87%) | (13.11%) | 0.87% | 15.58% | 28.82% | 27.71% | 31.21% |
Average Days of Receivables |
89.29 | 107.73 | 47.94 | 180.53 | 215.26 | 209.42 | 124.90 | 56.55 | 48.40 |
Research and Development Expense of Revenue |
0.07% | 1.59% | 2.65% | 2.91% | 4.66% | 4.54% | 5.81% | 11.25% | 9.61% |
Selling, General and Administrative Expense of Revenue |
99.38% | 56.74% | 68.99% | 62.89% | 55.23% | 36.50% | 38.44% | 28.66% | 39.27% |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.00 | 0.17 | 0.01 | 0.00 | 0.02 | 0.03 | 0.00 |
Share Based Compensation of Revenue |
32.57% | 0.69% | 0.70% | 1.14% | 1.30% | 0.94% | 1.08% | (0.11%) | 0.00% |
Graham Net Nets |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Graham Number |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Earnings Yield |
(0.05%) | (0.01%) | (0.01%) | 0.00% | 0.00% | 0.00% | 4.00% | 4.00% | 4.00% |
Free Cash Flow Yield |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Revenue per Share |
618.21 | 4,532.80 | 10,796.61 | 8,324.41 | 9,586.35 | 11,243.63 | 9,921.87 | 9,189.93 | 0.39 |
Operating CF per Share |
45.95 | (420.91) | 30.11 | (389.24) | 1,683.41 | (648.62) | 938.67 | 937.57 | (0.02) |
Capex per Share |
(8.29) | (870.06) | (448.94) | (296.18) | (1,058.76) | (100.37) | (875.27) | (776.14) | 0.00 |
Free Cash Flow per Share |
37.65 | (1,290.97) | (418.83) | (685.41) | 624.65 | (749.00) | 63.40 | 161.43 | (0.02) |
Cash per Share |
756.66 | 3,738.23 | 7,470.28 | 7,081.71 | 8,359.47 | 10,691.19 | 5,221.73 | 6,487.29 | 0.19 |
Shareholders Equity per Share |
1,228.15 | 6,900.31 | 11,687.89 | 19,423.12 | 19,156.71 | 19,896.31 | 10,225.67 | 8,132.43 | 0.21 |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
1,228.15 | 6,900.31 | 11,687.89 | 19,423.12 | 19,156.71 | 19,896.31 | 10,225.67 | 8,132.43 | 0.21 |
Free Cash Flow |
0.69 | (4.52) | (0.75) | (1.17) | 1.06 | (1.20) | 0.10 | 0.23 | (0.54) |
Working Capital |
15.44 | 17.18 | 16.03 | 18.54 | 23.67 | 26.61 | 12.15 | 10.23 | 4.85 |
Capital Expenditures |
(0.15) | (3.05) | (0.81) | (0.50) | (1.80) | (0.16) | (1.31) | (1.09) | (0.08) |
Net Current Asset Value |
15.41 | 16.97 | 15.33 | 17.11 | 23.55 | 26.61 | 12.11 | 9.90 | 4.85 |
EV/EBIT |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Capex to Sales |
0.01 | 0.19 | 0.04 | 0.04 | 0.11 | 0.01 | 0.09 | 0.08 | 0.00 |
Price to Operating Income |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other line items | |||||||||
Depreciation/Fixed assets |
0.05 | 0.04 | 0.16 | 0.10 | 0.09 | 0.10 | 0.05 | 0.06 | 0.31 |
Cash ROIC |
1.90% | (12.13%) | (2.19%) | (2.59%) | 2.27% | (2.45%) | 0.41% | 1.07% | (5.37%) |
Accounts Receivable Turnover |
3.05 | 4.39 | 4.07 | 1.70 | 1.64 | 2.33 | 4.20 | 7.81 | 5.96 |
Accounts Payable Turnover |
11.79 | 11.41 | 26.49 | 86.75 | 30.66 | 23.28 | 66.18 | 14.71 | 13.11 |
Inventory Turnover |
0.00 | 11.80 | 27.95 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Average Days of Payables |
30.71 | 28.09 | 22.86 | 6.59 | 2.07 | 24.37 | 9.18 | 1.93 | 53.52 |
Days of Inventory on Hand |
0.00 | 30.77 | 19.80 | 8.85 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Average Receivables |
3.73 | 3.62 | 4.78 | 8.31 | 9.97 | 7.71 | 3.54 | 1.65 | 1.65 |
Average Payables |
0.53 | 0.61 | 0.41 | 0.09 | 0.22 | 0.26 | 0.07 | 0.30 | 0.30 |
Average Inventory |
— | 0.59 | 0.39 | — | — | — | — | — | — |
Average Assets |
25.02 | 25.15 | 31.52 | 37.44 | 35.54 | 26.28 | 15.89 | 7.02 | 10.51 |
Average Common Equity |
23.37 | 22.59 | 27.03 | 32.79 | 32.20 | 23.59 | 13.36 | 8.30 | 8.31 |
Columns are period end dates · fundamentals updated 3 Nov 2026